Literature DB >> 1555039

Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships.

C M Deighton1, J W Gray, A J Bint, D J Walker.   

Abstract

One hundred and forty-two RA patients and 121 of their healthy same-sexed siblings were tested for antibodies (Abs) to Proteus mirabilis and Escherichia coli by indirect immunofluorescence. Eighty-five individuals had active RA (CRP greater than 10 mg/l) and 57 inactive RA. The anti-Proteus Ab titre in the active RA group was significantly higher than in the inactive RA and non-RA group (P less than 0.0001 in both cases). Anti-Proteus Abs were significantly elevated in 30 individuals with active RA compared with their healthy HLA-identical same-sexed siblings (P less than 0.001). In 42 HLA-DR4 positive and 15 HLA-DR4 negative active RA patients, the Ab titre was non-significantly higher in the former group. Anti-E. coli Abs were not significantly elevated in any of the groups. Longitudinal data on 36 RA patients demonstrated a significant positive correlation between changes in CRP and changes in anti-Proteus antibody titres (r = 0.52, P less than 0.001). These observations require an explanation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555039     DOI: 10.1093/rheumatology/31.4.241

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  12 in total

1.  Specificity of the proteus antibody response in rheumatoid arthritis.

Authors:  C M Deighton; J Gray; A J Bint; D J Walker
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis.

Authors:  C Wilson; A Thakore; D Isenberg; A Ebringer
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

Review 3.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

4.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

5.  Proteus--is it a likely aetiological factor in chronic polyarthritis?

Authors:  H Gaston
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

6.  Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis.

Authors:  D M B T Disaanayake; Joan Faoagali; Hans Laroo; Gerald Hancock; Michael Whitehouse
Journal:  Inflammopharmacology       Date:  2014-01-05       Impact factor: 4.473

7.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 8.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy.

Authors:  A Ebringer; K Ahmadi; M Fielder; T Rashid; H Tiwana; C Wilson; A Collado; Y Tani
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

10.  P blood group phenotype, proteus antibody titres, and rheumatoid arthritis.

Authors:  C M Deighton; J Gray; D F Roberts; A J Bint; D J Walker
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.